Evidence map›Paper›PMID 36340141›Full record

ArticleACS omega2022

Amr A Abd-Elghany, Samya Mahmoud Ahmed, Marwa A Masoud, Tarek Atia, Hisham Ali Waggiallah, Mohamed A El-Sakhawy, Ebtesam A Mohamad

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Cardioprotective Potential ofCurrent pharmaceutical biotechnology · 2025
    Article
  2. Article
  3. Niosomes loading N-acetyl-L-cysteine for cancer treatment in vivo study.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  4. Chitosan andToxicology research · 2024
    Article
  5. Influence of methanolic extracts from seeds and pulp ofCurrent research in toxicology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Amr A Abd-ElghanyRadiology and Medical Imaging Department, College of Applied Medical Sciences, Prince Sattam Bin Abdul-Aziz University, Al-Kharj11942, Saudi Arabia.ORCID https://orcid.org/0000-0002-7179-2290
Samya Mahmoud AhmedDepartment of Biochemistry, National Organization for Drug Control and Research (NODCAR), Egyptian Drug Authority (EDA), Giza12654, Egypt.
Marwa A MasoudDepartment of Pharmacology, National Organization for Drug Control and Research (NODCAR), Egyptian Drug Authority (EDA), Giza12654, Egypt.
Tarek AtiaDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdul-Aziz University, Al-Kharj11942, Saudi Arabia.ORCID https://orcid.org/0000-0001-8236-5051
Hisham Ali WaggiallahDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdul-Aziz University, Al-Kharj11942, Saudi Arabia.
Mohamed A El-SakhawyDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdul-Aziz University, Al-Kharj11942, Saudi Arabia.
Ebtesam A MohamadRadiology and Medical Imaging Department, College of Applied Medical Sciences, Prince Sattam Bin Abdul-Aziz University, Al-Kharj11942, Saudi Arabia.
Prince Sattam Bin Abdulaziz University · SANational Organization for Drug Control and Research · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current research is focused on cancer treatments other than chemotherapy medications, particularly those derived from natural sources. The goal of this work was to look at the anticancer and biomarker properties of a methanolic extract of

Identifiers

PMID36340141
PMCPMC9631742
OpenAlexW4306990279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.